DR — Medical Facilities Income Statement
0.000.00%
Last trade - 00:00
- CA$322.19m
- CA$553.29m
- $445.58m
- 91
- 78
- 87
- 99
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 398 | 364 | 399 | 425 | 446 |
Cost of Revenue | |||||
Gross Profit | 270 | 243 | 269 | 281 | 297 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 354 | 296 | 321 | 390 | 376 |
Operating Profit | 44.6 | 67.8 | 77.4 | 34.9 | 69.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 71.7 | 41.8 | 50.9 | 17.5 | 52.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 59.7 | 37.4 | 46.5 | 12.3 | 44 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 9.82 | 8.81 | 15.5 | -4.41 | 18.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -15.7 | 8.81 | 15.5 | -4.41 | 18.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.995 | -0.41 | 0.114 | 0.489 | 0.65 |
Dividends per Share |